Global Carglumic Acid Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Carglumic Acid Sales Market Report 2024
Market Analysis and InsightsGlobal Carglumic Acid Market
Carglumic acid is an orphan drug that is used for treating patients suffering from hyperammonemia, a urea cycle disorder that is caused due to the lack of a certain enzyme in the liver.
Due to the COVID-19 pandemic, the global Carglumic Acid market size is estimated to be worth US$ 60 million in 2024 and is forecast to a readjusted size of US$ 81 million by 2034 with a CAGR of 4.0% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Orally Disintegrating Tablet accounting for % of the Carglumic Acid global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
The United States Carglumic Acid market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Carglumic Acid include Recordati, Civentichem and Dipharma, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Carglumic Acid Scope and Market Size
The global Carglumic Acid market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Carglumic Acid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Orally Disintegrating Tablet
Tablets for Oral Suspension
Hospital Pharmacies
Retail Pharmacies
E-Commerce
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
Recordati
Civentichem
Dipharma
Carglumic acid is an orphan drug that is used for treating patients suffering from hyperammonemia, a urea cycle disorder that is caused due to the lack of a certain enzyme in the liver.
Due to the COVID-19 pandemic, the global Carglumic Acid market size is estimated to be worth US$ 60 million in 2024 and is forecast to a readjusted size of US$ 81 million by 2034 with a CAGR of 4.0% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Orally Disintegrating Tablet accounting for % of the Carglumic Acid global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Hospital Pharmacies segment is altered to an % CAGR throughout this forecast period.
The United States Carglumic Acid market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Carglumic Acid include Recordati, Civentichem and Dipharma, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Carglumic Acid Scope and Market Size
The global Carglumic Acid market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Carglumic Acid market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Orally Disintegrating Tablet
Tablets for Oral Suspension
Segment by Application
Hospital Pharmacies
Retail Pharmacies
E-Commerce
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Recordati
Civentichem
Dipharma
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices